APA

Clark J. I., Kuzel T. M., Lestingi T. M., Fisher S. G., Sorokin P., Martone B., Viola M. & Sosman J. A. (20021217). A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Clark J I, Kuzel T M, Lestingi T M, Fisher S G, Sorokin P, Martone B, Viola M and Sosman J A. 20021217. A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Clark J. I., Kuzel T. M., Lestingi T. M., Fisher S. G., Sorokin P., Martone B., Viola M. and Sosman J. A. (20021217). A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Clark J I, Kuzel T M, Lestingi T M, Fisher S G, Sorokin P, Martone B, Viola M and Sosman J A. A multi-institutional phase II trial of a novel inpatient schedule of continuous interleukin-2 with interferon alpha-2b in advanced renal cell carcinoma: major durable responses in a less highly selected patient population. : Annals of oncology : official journal of the European Society for Medical Oncology. 20021217.